1. Extended follow-up with the Bruton's tyrosine kinase inhibitor ibrutinib in previously treated Waldenström's macroglobulinemia. Issue 6 (3rd June 2017) Authors: Furman, Richard R.; Luan, Ying; Bilotti, Elizabeth; Graef, Thorsten Journal: Leukemia & lymphoma Issue: Volume 58:Issue 6(2017) Page Start: 1502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis. (2nd December 2018) Authors: Brown, Jennifer R.; Moslehi, Javid; Ewer, Michael S.; O'Brien, Susan M.; Ghia, Paolo; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Coutre, Steven E.; Dilhuydy, Marie‐Sarah; Cramer, Paula; Jaeger, Ulrich; Dreyling, Martin; Byrd, John C.; Treon, Steven; Liu, Emily Y.; Chan... Journal: British journal of haematology Issue: Volume 184:Number 4(2019) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies. (10th February 2019) Authors: Burger, Jan A.; Cramer, Paula; Barr, Paul M.; Dilhuydy, Marie‐Sarah; Mato, Anthony; Byrd, John C.; Chang, Stephen; Graef, Thorsten; Lin, Tony; Tedeschi, Alessandra Journal: British journal of haematology Issue: Volume 186:Number 1(2019) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemia. Issue 8 (3rd August 2017) Authors: Vey, Norbert; Prebet, Thomas; Thalamas, Claire; Charbonnier, Aude; Rey, Jerome; Kloos, Ioana; Liu, Emily; Luan, Ying; Vezan, Remus; Graef, Thorsten; Recher, Christian Journal: Leukemia & lymphoma Issue: Volume 58:Issue 8(2017) Page Start: 1880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial. Issue 2 (February 2017) Authors: Dimopoulos, Meletios A; Trotman, Judith; Tedeschi, Alessandra; Matous, Jeffrey V; Macdonald, David; Tam, Constantine; Tournilhac, Olivier; Ma, Shuo; Oriol, Albert; Heffner, Leonard T; Shustik, Chaim; García-Sanz, Ramón; Cornell, Robert F; de Larrea, Carlos Fernández; Castillo, Jorge J; Granell, M... Journal: Lancet oncology Issue: Volume 18:Issue 2(2017:Feb.) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review. Issue 7 (July 2018) Authors: Buske, Christian; Sadullah, Shalal; Kastritis, Efstathios; Tedeschi, Alessandra; García-Sanz, Ramón; Bolkun, Lukasz; Leleu, Xavier; Willenbacher, Wolfgang; Hájek, Roman; Minnema, Monique C; Cheng, Mei; Bilotti, Elizabeth; Graef, Thorsten; Dimopoulos, Meletios A Journal: Lancet Issue: Volume 5:Issue 7(2018) Page Start: e299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma. Issue 11 (2nd November 2018) Authors: Chari, Ajai; Larson, Sarah; Holkova, Beata; Cornell, Robert F.; Gasparetto, Cristina; Karanes, Chatchada; Matous, Jeffrey V.; Niesvizky, Ruben; Valent, Jason; Lunning, Matthew; Usmani, Saad Z.; Anderson, Larry D.; Chang, Lipo; Lee, Yihua; Pak, Yvonne; Salman, Zeena; Graef, Thorsten; Bilotti, Eliz... Journal: Leukemia & lymphoma Issue: Volume 59:Issue 11(2018) Page Start: 2588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results. (13th February 2018) Authors: Richardson, Paul G.; Bensinger, William I.; Huff, Carol Ann; Costello, Caitlin L.; Lendvai, Nikoletta; Berdeja, Jesus G.; Anderson, Larry D.; Siegel, David S.; Lebovic, Daniel; Jagannath, Sundar; Laubach, Jacob P.; Stockerl‐Goldstein, Keith E.; Kwei, Long; Clow, Fong; Elias, Laurence; Salman, Zee... Journal: British journal of haematology Issue: Volume 180:Number 6(2018) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗